Why Argireline is a cosmetic, not a Botox replacement, and how to track whether it is actually doing anything for your skin.
A practical tracking guide for the DAC version of CJC-1295, with weekly dosing rationale and IGF-1 expectations.
What Thymalin is, where the Khavinson research comes from, and how to track a cycle if you choose to run one.
What AHK-Cu is, how it compares to GHK-Cu, and how to track hair, scalp, and skin changes if you choose to use it.
How glutathione works, route differences, and what a self-experimenter should actually measure.
A pragmatic log structure for ipamorelin used on its own, separate from the common CJC-1295 stack.
What NR is, how it compares to NMN, and how to track realistic outcomes from a vitamin B3 derivative marketed for cellular aging.
How the short-acting GHRH analog works, why it mimics natural GH pulses, and what to track when using it.
What to know about using a pre-mixed CJC-1295/ipamorelin blend versus separate vials, and how it affects your tracking.
A tracking guide for metformin that takes its prescription status and side effects seriously.
A tracking guide for sermorelin, the 29-amino-acid GHRH analog, with realistic expectations for sleep, recovery, and IGF-1 changes.
What MOTS-c does, what it might do in humans, and how to track it honestly.
A practical guide to tracking GHK-Cu protocols — what to measure, what to photograph, and what the realistic timelines look like.
A practical look at pre-mixed sermorelin/ipamorelin blends — the GHRH plus GHRP rationale and the tracking tradeoffs of using one syringe.
A small peptide encoded in mitochondrial DNA with intriguing but very early evidence.
A tracking guide for direct NAD+ supplementation that takes the cost and evidence seriously.
A careful tracking guide for recombinant human growth hormone, focused on what to monitor when using a prescription compound with real metabolic consequences.
What Pinealon is, where it sits in the Khavinson peptide family, and how to track its proposed cognitive and stress effects honestly.
A tracking guide for SS-31/elamipretide, the cardiolipin-binding peptide studied in mitochondrial disease and heart failure.
What Vilon is, where the research comes from, realistic expectations, and how to track a course if you choose to run one.
A tracking guide for NMN supplementation focused on what is actually measurable in humans.
How to think about and track proprietary multi-peptide blends marketed as one product, with honest limits on attribution.
Two growth-hormone-releasing peptides that are usually used together. How they differ, how protocols are structured, and what to track.
What tesamorelin is, how protocols are structured, what to measure if you want to evaluate effects on visceral fat, energy, and sleep.
Epitalon protocols last days, not weeks, and effects accumulate across cycles. Here is what to track if you want personal data that compounds over years.